Key takeaways
- IV therapy may be very effective at improving the symptoms of COVID.
- IV therapy can help stabilize vital signs, manage fluid balance, and deliver medications or nutrients directly into the bloodstream.
- Scientists have attested to the therapeutic roles of IV vitamin C, IV immunoglobulin and IV immune boost for improving symptoms of COVID.
- IV therapy can help manage dehydration, replenish electrolytes, provide essential nutrients, and deliver antiviral medications or immunoglobulins directly into the bloodstream to support the body’s ability to fight the virus.
- IV therapy for COVID-19 is generally safe when administered by trained healthcare professionals in a clinical setting.v
- IV therapy is not a preventive measure for COVID-19 infection. It is primarily used as a supportive treatment for individuals who have already contracted the virus to manage symptoms and support recovery.
Using IV therapy for COVID may serve as an excellent way to manage symptoms since they deliver medications and IV fluids directly into the bloodstream. This allows for faster absorption and better response in individuals with moderate to chronic forms of COVID. In this article, we would look at the possible roles of IV therapy in COVID and the common side effects linked to it.
Is IV therapy effective against COVID?
Yes, researchers have discovered the potential use of different IV therapies that could help in improving symptoms of COVID-19 and also deliver high dose and effective antiviral medications directly into the blood stream. Some of the commonly reported IV therapies for COVID-19 include but are not limited to IV vitamin C, IV immunoglobulin therapy and Myres Super Immune Boost IVs.
IV therapy for COVID like the Myres Super Immune Boosts IVs presents a potent treatment option available in the comfort of your own home, devoid of adverse effects, whether combating a common cold or a more severe ailment. When our immune system is compromised during illness, it may struggle to produce T-cells, which regulate blood pressure and combat fatigue, leaving the body vulnerable to stress and disease. Myers Super Immune Boost IVs deliver T-cell therapy directly into the bloodstream, enhancing immune function and swiftly alleviating discomfort.
Additionally, it provides a robust antioxidant infusion to aid in restoring the function of blood, liver, and kidneys. In certain instances, it may even reduce recovery time following surgery or infection, facilitating a quicker return to normalcy. This safe and efficient IV treatment initiates its effects almost immediately, delivering rapid relief in the comfort of your home without the need for an appointment or prescription.
Benefits of IV therapy for COVID
- Direct Delivery of Antiviral Medications: IV therapy allows for the delivery of high doses of effective antiviral medications directly into the bloodstream, potentially improving COVID-19 symptoms and aiding in the fight against the virus.
- Antioxidant Support: IV therapy provides a robust antioxidant infusion, which may aid in restoring the function of vital organs such as the blood, liver, and kidneys, potentially reducing the risk of complications associated with COVID-19.
- Reduced Recovery Time: In some cases, IV therapy, such as Myers Super Immune Boost IVs, may help reduce recovery time following COVID-19 infection, thus facilitating a quicker return to normalcy and improving overall well-being.
- Safe and Efficient Treatment: IV therapy for COVID-19 is safe and efficient, with minimal adverse effects reported. It can be administered in the comfort of one’s home, providing rapid relief without the need for an appointment or prescription.
Side effects of IV therapy for COVID
While IV therapy for COVID-19 can offer benefits, it’s essential to consider potential side effects. Here are some possible side effects associated with IV therapy for COVID-19:
- Injection Site Reactions: Some individuals may experience mild discomfort, bruising, or swelling at the injection site where the IV catheter is inserted.
- Allergic Reactions: Rarely, individuals may experience allergic reactions to components of the IV therapy solution, resulting in symptoms such as itching, rash, hives, or difficulty breathing.
- Fluid Overload: Administration of IV fluids can lead to fluid overload, especially in individuals with impaired kidney function or heart disease, potentially causing swelling, shortness of breath, or high blood pressure.
- Electrolyte Imbalance: IV therapy may disrupt electrolyte balance, leading to abnormalities such as low or high levels of potassium, sodium, calcium, or magnesium in the blood, which can cause symptoms like muscle cramps, weakness, or irregular heartbeat.
- Infection: There is a risk of infection at the site of the IV catheter insertion, which can lead to local inflammation, redness, warmth, or tenderness. In severe cases, bloodstream infections (septicemia) may occur.
- Thrombosis: Prolonged IV therapy or the use of certain medications may increase the risk of blood clots (thrombosis), which can lead to complications such as deep vein thrombosis (DVT) or pulmonary embolism (PE).
- Kidney Injury: IV therapy, particularly with certain medications or fluids, may increase the risk of acute kidney injury, especially in individuals with pre-existing kidney disease or dehydration.
- Adverse Drug Reactions: Some medications administered via IV therapy may cause adverse drug reactions, including nausea, vomiting, diarrhea, headache, dizziness, or changes in blood pressure or heart rate.
- Dizziness or Fainting: Rapid administration of IV fluids or medications may cause dizziness or fainting in some individuals, particularly those prone to low blood pressure or dehydration.
Frequently asked Questions
How does IV therapy help in treating COVID-19?
IV therapy can help manage dehydration, replenish electrolytes, provide essential nutrients, and deliver antiviral medications or immunoglobulins directly into the bloodstream to support the body’s ability to fight the virus.
Who is eligible for IV therapy for COVID-19?
Individuals with COVID-19 who experience dehydration, severe symptoms, or complications such as respiratory distress may be candidates for IV therapy. Eligibility is determined by healthcare providers based on individual medical needs.
What types of IV therapies are used for COVID-19?
Common IV therapies for COVID-19 include fluids for hydration, electrolyte solutions, antiviral medications, immunoglobulin therapy, and vitamin or nutrient infusions to support immune function and overall health.
Is IV therapy for COVID-19 safe?
IV therapy for COVID-19 is generally safe when administered by trained healthcare professionals in a clinical setting. However, like any medical intervention, there are potential risks and side effects that should be monitored and managed by healthcare providers.
Can IV therapy prevent COVID-19 infection?
IV therapy is not a preventive measure for COVID-19 infection. It is primarily used as a supportive treatment for individuals who have already contracted the virus to manage symptoms and support recovery.
What role does IV therapy play in severe cases of COVID-19?
In severe cases of COVID-19, IV therapy is often used as part of supportive care measures provided to patients in hospitals. It can help stabilize vital signs, manage fluid balance, and deliver medications or nutrients directly into the bloodstream.
Can IV therapy be used as a primary treatment for COVID-19?
IV therapy is not typically used as a primary treatment for COVID-19. It is primarily used as a supportive treatment to manage symptoms and support recovery in individuals who have contracted the virus.
Are there any specific medications or supplements administered through IV therapy for COVID-19?
Depending on individual medical needs and treatment protocols, medications such as antivirals, corticosteroids, or monoclonal antibodies may be administered through IV therapy for COVID-19. Additionally, supplements such as vitamin C or zinc may be included to support immune function.
Sources
The LOVIT-COVID Investigators, on behalf of the Canadian Critical Care Trials Group, and the REMAP-CAP Investigators. Intravenous Vitamin C for Patients Hospitalized With COVID-19: Two Harmonized Randomized Clinical Trials. JAMA. 2023;330(18):1745–1759. doi:10.1001/jama.2023.21407
Niknam, Z., Jafari, A., Golchin, A. et al. Potential therapeutic options for COVID-19: an update on current evidence. Eur J Med Res 27, 6 (2022). https://doi.org/10.1186/s40001-021-00626-3
Hiedra, R., Lo, K. B., Elbashabsheh, M., Gul, F., Wright, R. M., Albano, J., Azmaiparashvili, Z., & Aponte, G. P. (2020). The use of IV vitamin C for patients with COVID-19: A case series. Expert Review of Anti-Infective Therapy, 1-3. https://doi.org/10.1080/14787210.2020.1794819
Ao, G., Li, J., Yuan, Y., Wang, Y., Nasr, B., Bao, M., Gao, M., & Qi, X. (2022). Intravenous vitamin C use and risk of severity and mortality in COVID‐19: A systematic review and meta‐analysis. Nutrition in Clinical Practice, 37(2), 274-281. https://doi.org/10.1002/ncp.10832
What Kind of IV Therapy Works Best for COVID Recovery. https://driphydration.com/blog/what-kind-of-iv-therapy-works-best-for-covid-recovery/. Accessed 2/16/2024
